Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
57 studies found for:    "Cushings syndrome"
Show Display Options
Rank Status Study
21 Recruiting An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease
Condition: Cushing's Disease
Intervention: Drug: Pasireotide sub-cutaneous formulation
22 Recruiting Safety and Efficacy of LCI699 in Cushing's Disease Patients.
Condition: Cushing's Disease
Intervention: Drug: LCI699
23 Recruiting Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease
Condition: Cushing's Disease
Interventions: Drug: SOM230 LAR 30 mg;   Drug: SOM230 LAR 10 mg
24 Recruiting Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Condition: Cushing's Disease
Intervention: Drug: LCI699
25 Completed A Study to Assess SOM230 in Patients With Pituitary Cushing's Disease
Condition: Cushing's Syndrome
Intervention: Drug: SOM230 s.c.
26 Recruiting Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly
Conditions: Cushing's Disease,;   Acromegaly
Interventions: Drug: Pasireotide s.c.;   Drug: Sitagliptin;   Drug: Liraglutide;   Drug: Insulin;   Drug: Pasireotide LAR;   Drug: Metformin
27 Completed
Has Results
Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease
Condition: Cushing's Disease
Intervention: Drug: Pasireotide
28 Recruiting Glucocorticoid Receptor Blockade With Mifepristone in Patients With Mild Adrenal Hypercortisolism
Condition: Mild Hypercortisolism
Intervention: Drug: Mifepristone
29 Recruiting Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease
Condition: Cushing's Disease
Interventions: Drug: Pasireotide;   Drug: Cabergoline
30 Completed Study of Cushing's Syndrome Not Related to ACTH Production
Conditions: Cushing's Syndrome;   Healthy
Intervention:
31 Unknown  Study of Depression, Peptides, and Steroids in Cushing's Syndrome
Condition: Cushing's Syndrome
Intervention:
32 Active, not recruiting Diagnostic Performance of Screening Tests for Cushing s Syndrome
Condition: Cushing's Syndrome
Intervention:
33 Completed Hippocampal Complex Volume and Memory Dysfunction in Cushing's Syndrome
Condition: Cushing's Syndrome
Intervention:
34 Unknown  Study of Hypercortisolism in Cushing's Syndrome and Stress-Induced Pseudo-Cushing's Syndrome
Condition: Cushing's Syndrome
Intervention:
35 Recruiting Adrenalectomy Versus Follow-up in Patients With Subclinical Cushings Syndrome
Condition: Adrenal Tumour With Mild Hypercortisolism
Intervention: Procedure: Adrenalectomy
36 Unknown  Preoperative Bexarotene Treatment for Cushing's Disease
Condition: Cushing's Disease
Intervention: Drug: Bexarotene
37 Completed The Factors Associated With the Recurrence in Patients With Cushing Disease
Condition: Cushing Disease
Intervention:
38 Terminated Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)
Condition: Cushing's Disease
Interventions: Drug: rosiglitazone maleate;   Other: laboratory biomarker analysis
39 Completed Dose Response Relationship for Single Doses of Corticotropin Releasing Hormone (CRH) in Normal Volunteers and in Patients With Adrenal Insufficiency
Conditions: Adrenal Gland Hyperfunction;   Adrenal Gland Hypofunction;   Cushing's Syndrome;   Healthy
Intervention: Drug: Ovine Corticotropin-Releasing Hormone (oCRH)
40 Recruiting An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Conditions: Abnormalities;   Craniopharyngioma;   Cushing's Syndrome;   Endocrine Disease;   Pituitary Neoplasm
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-57) Show next page of results    Last Page
Indicates status has not been verified in more than two years